[Federal Register Volume 75, Number 172 (Tuesday, September 7, 2010)]
[Notices]
[Pages 54348-54349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-22183]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and

[[Page 54349]]

the discussions could disclose confidential trade secrets or commercial 
property such as patentable materials, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Clinical Science Conference Grant (R13) Review.
    Date: September 29, 2010.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852. (Virtual Meeting)
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401. 301-402-6626. <a href="/cdn-cgi/l/email-protection#7f18124e4b4a1e3f11161751181009"><span class="__cf_email__" data-cfemail="30575d01040551705e59581e575f46">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA B/Start Small Grant Review.
    Date: October 20, 2010.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852. (Virtual Meeting)
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401. 301-402-6626. <a href="/cdn-cgi/l/email-protection#7d1a104c49481c3d131415531a120b"><span class="__cf_email__" data-cfemail="97f0faa6a3a2f6d7f9feffb9f0f8e1">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: November 3-5, 2010.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1150 22nd Street, NW., Rockville, MD 
20852, Washington, DC 20037.
    Contact Person: Kristen V. Huntley, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. 301-435-1433. <a href="/cdn-cgi/l/email-protection#234b564d574f465a48634e424a4f0d4d4a4b0d444c55"><span class="__cf_email__" data-cfemail="99f1ecf7edf5fce0f2d9f4f8f0f5b7f7f0f1b7fef6ef">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA I/Start Small Grant Review.
    Date: November 10, 2010.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852. (Virtual Meeting.)
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401. 301-402-6626. <a href="/cdn-cgi/l/email-protection#cdaaa0fcf9f8ac8da3a4a5e3aaa2bb"><span class="__cf_email__" data-cfemail="f59298c4c1c094b59b9c9ddb929a83">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: August 31, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-22183 Filed 9-3-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>